LMWH plays a crucial role in gynecology for a variety of reasons. It is used to manage conditions like venous thromboembolism (VTE), deep vein thrombosis (DVT), and pulmonary embolism (PE) which can occur during pregnancy, post-surgery, or in women with underlying clotting disorders. Its predictable pharmacokinetics and subcutaneous administration make it a preferred choice over unfractionated heparin (UFH).
